Home
AMPAC Fine Chemicals

AMPAC Fine Chemicals Market Share Analysis for November 2025

As a leading global CDMO, SK pharmteco provides drug development and manufacturing services for small molecule, biologic, cell and gene therapies.

Health > Biotechnology and Pharmaceuticals

Domainampacfinechemicals.com

Year Founded1998

Employees501 - 1000

Annual Revenue$100M - $200M

AMPAC Fine Chemicals

AMPAC Fine Chemicals (including company regionals)

ampacfinechemicals.com

See more website traffic and engagement information

AMPAC Fine Chemicals Revenue up to November 2025 is 100M - 200M

revenue generated by AMPAC Fine Chemicals top domains

AMPAC Fine Chemicals top domains revenue over 3 years

Revenue for AMPAC Fine Chemicals top domains

ampacfinechemicals.com100M - 200M

See more with Sales Intelligence

Total visits to AMPAC Fine Chemicals's top domains

Understand AMPAC Fine Chemicals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in AMPAC Fine Chemicals's top domains

Analyze AMPAC Fine Chemicals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on AMPAC Fine Chemicals's top domains

See how AMPAC Fine Chemicals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

AMPAC Fine Chemicals top competitors by domain

Top similar sites in November 2025, ranked by their affinity

skpharmteco.comCompany NameSK Pharmteco Inc.Employees1001 - 5000HQUnited States, California, Rancho CordovaAnnual revenue$500M - $1BTotal visits10.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by AMPAC Fine Chemicals

These are the website technologies, by industry, used by AMPAC Fine Chemicals top domains

Widget (7)

reCAPTCHA

Advertising (3)

DoubleClick

Content Management System (3)

WordPress

Mobile (2)

Meta Viewport

More Technologies

8

See all

News & Signals from AMPAC Fine Chemicals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAmpacfinechemicals sold assets to SK pharmteco Inc. in the amount of $576M on Jan 1st '18.SK Pharmteco has operated the facility since it acquired it from Ampac Fine Chemicals in 2018 for around 800 billion won ($576 million).

NewsAmpacfinechemicals is developing COVID drugs.In Petersburg, Phlow is partnering with nonprofit generic drugmaker Civica Rx and California-based AMPAC Fine Chemicals to produce COVID drugs as part of a federal initiative to create the domestic supply chain for critical pharmaceuticals and ingredients.

NewsAmpacfinechemicals is developing COVID drugs.In Petersburg, Phlow is partnering with nonprofit generic drug-maker Civica Rx and California-based AMPAC Fine Chemicals to produce COVID drugs as part of a federal initiative to create the domestic supply chain for critical pharmaceuticals and ingredients.